Document Detail


Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
MedLine Citation:
PMID:  20590702     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. OBJECTIVE: To update guidelines for sclerotherapy of varicose veins. METHODS: The guidelines for sclerotherapy of varicose veins of the German Society of Phlebology were updated and modified through a review of the available literature. RESULTS: Published clinical series and controlled clinical trials provide evidence to support the elimination of intracutaneous and subcutaneous varicose veins using sclerotherapy. Allergic skin reactions occur occasionally as allergic dermatitis, contact urticaria, or erythema. Anaphylaxis is rare. Transient migraine headaches present more frequently in patients treated with foam sclerotherapy than liquid sclerotherapy. CONCLUSION: Sclerotherapy is the method of choice for the treatment of small-caliber varicose veins (reticular varicose veins, spider veins). If performed properly, sclerotherapy is an efficient treatment method with a low incidence of complications.
Authors:
Eberhard Rabe; Felizitas Pannier
Publication Detail:
Type:  Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]     Volume:  36 Suppl 2     ISSN:  1524-4725     ISO Abbreviation:  Dermatol Surg     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-01     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504371     Medline TA:  Dermatol Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  968-75     Citation Subset:  IM    
Affiliation:
Department of Dermatology, University of Bonn, Bonn, Germany. Eberhard.Rabe@ukb.uni-bonn.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Germany
Humans
Polyethylene Glycols / administration & dosage*,  adverse effects
Sclerosing Solutions / administration & dosage*,  adverse effects
Sclerotherapy / adverse effects,  contraindications,  standards*
Varicose Veins / therapy*
Chemical
Reg. No./Substance:
0/Polyethylene Glycols; 0/Sclerosing Solutions; 9002-92-0/polidocanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Progressive interstitial fibrosis of kidney allograft early after transplantation from a non-heart b...
Next Document:  Choosing the appropriate sclerosing concentration for vessel diameter.